‘At the Limits’ is the international medical education series which enables leading academics and scientists to meet with senior opinion leaders and prescribers in an inspiring and stimulating academic environment. The meetings are supported by Industry and we encourage sponsors to attend with a delegation of senior medical personnel to build and maintain the relationships between medicine and industry which are so essential for the development and understanding of successful future patient care.
The next ATL meetings will take place in Spring 2017 at the Royal College of Physicians in London & the University of Cape Town in South Africa.
Please register to be kept informed of upcoming events and developments.
*CDNATL 2015 & 2016 delegate feedback surveys
In association with our colleagues at the UCL Cancer Institute we’re creating six new 1-day meetings in 2016 to update practicing oncologists, nurses and scientists on advances in specific tumor types; Haematology, Urology, Women’s Health, Lung, Cardio-Oncology, and Gastrointestinal and Neuroendocrine Oncology. The meetings will be held at UCL and feature presentations and discussions designed to enable oncologists to enhance cancer care and understand the breakthroughs which will directly affect them and their patients.
‘At the Limits’ is pleased to announce a new event in 2017, the inaugural
Accelerating Cancer Immunotherapy Conference
to be held in London from 30th – 31st March 2017.
The Chairman, Dr Sergio Quezada (UCL, London), is bringing together the global leaders in cancer immunotherapy discovery with front-line clinicians, payers, investors and journalists to build a dedicated European immunotherapy community, and to accelerate knowledge in this fastest moving area of Oncology.
We’ll announce the speakers and programme in Summer 2016, so register now to receive information as soon as it’s announced, and to have ‘early-bird’ offers sent straight to your inbox.
To discuss the opportunity of sponsorship please contact David Jones, Events Director, for further details; email@example.com